文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

COVID-19患者床旁气管切开术中使用新型负压帐篷

Use of a Novel Negative-Pressure Tent During Bedside Tracheostomy in COVID-19 Patients.
PubMed 文献 · Neurocrit Care · 2020-08-07
一句话结论对3例插管COVID-19患者,使用AerosolVE负压帐篷完成经皮扩张气管切开和支气管镜检查,无并发症,作者认为可行。

该回顾性病例系列描述了3例插管COVID-19合并神经系统疾病和呼吸衰竭的成人患者,在AerosolVE负压帐篷内由神经重症医师行经皮扩张气管切开术(PDT),并均以实时超声引导完成,支气管镜用于确认导管位置和肺部清理,无并发症发生。AerosolVE帐篷为预制低成本负压帐篷,模拟气溶胶生成操作中颗粒物逸出可忽略。作者结论为在插管COVID-19患者中使用该帐篷行PDT可行,是可能降低医护人员风险的 promising 低成本装置。

要点

  • 对3例插管COVID-19成人患者(53岁男、53岁女、69岁男),在AerosolVE负压帐篷内成功完成经皮扩张气管切开术,无并发症。
  • 3例患者术前FiO2需求40-50%,PEEP 8-12 cm H2O,均在实时超声引导下完成PDT。
  • 支气管镜用于确认导管位置和肺部清理,在帐篷内完成。
  • AerosolVE帐篷为预制低成本负压帐篷,模拟气溶胶生成操作中颗粒物逸出可忽略。
  • 作者认为在插管COVID-19患者中使用该帐篷行PDT可行,是可能降低医护人员感染风险的低成本装置。

适用人群与场景

  • 插管成人COVID-19患者,合并神经系统疾病和呼吸衰竭,需要气管切开,术前FiO2 40-50%、PEEP 8-12 cm H2O。
  • 由神经重症医师在床旁操作。

处置流程与药物剂量

  • 将AerosolVE负压帐篷置于患者周围,帐篷为透明塑料罩,带手伸入的缝隙,连接U形底座带通风口,空气经高效微粒空气过滤器抽出并排到室外。
  • 在帐篷内行经皮扩张气管切开术,全程实时超声引导。
  • 在帐篷内行支气管镜确认导管位置和进行肺部清理。

研究设计与关键结果

  • 回顾性连续病例系列,共3例插管成人COVID-19患者,在AerosolVE负压帐篷内行经皮扩张气管切开术。
  • 3例患者均成功完成经皮扩张气管切开术和支气管镜操作,无并发症发生。
  • 模拟气溶胶生成操作初步测试显示,颗粒物逸出帐篷外可忽略。

证据类型、等级与局限

  • 证据类型:回顾性病例系列(3例)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在插管COVID-19患者中使用AerosolVE负压帐篷行经皮扩张气管切开术是可行的,是可能降低医护人员在气溶胶生成操作中感染风险的低成本装置。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Many COVID-19 patients with neurological manifestations and respiratory failure remain dependent on mechanical ventilation and require tracheostomy, which is an aerosol generating procedure (AGP). The risk of SARS-CoV-2 transmission to healthcare staff during AGPs is well documented, and negative-pressure rooms are often unavailable. Innovative techniques to decrease risk to healthcare providers during AGPs are necessary. Our objective was to demonstrate the feasibility of percutaneous dilatational tracheostomy (PDT) performed using a novel prefabricated low-cost negative-pressure tent (AerosolVE).

METHODS: Retrospective review of consecutive PDT procedures performed by neurointensivists on intubated adult patients with COVID-19 using the AerosolVE tent during the pandemic under an innovative clinical care protocol. The AerosolVE negative-pressure tent consists of a clear plastic canopy with slits for hand access attached to a U-shaped base with air vents. Air within the tent is drawn through a high-efficiency particulate air filter and released outside. Preliminary testing during simulated AGPs demonstrated negligible escape of particulate matter beyond the tent. The main outcome measure was successful completion of PDT and bronchoscopy within the AerosolVE tent, without complications.

RESULTS: The patients were a 53-year-old man with multifocal ischemic stroke and acute respiratory distress syndrome (ARDS), 53-year-old woman with cerebellar hemorrhage and ARDS, and a 69-year-old man with ARDS. Pre-procedure FiO2 requirement was 40-50% and positive end-expiratory pressure (PEEP) 8-12 cm H2O. The tent was successfully positioned around the patient and PDT completed with real-time ultrasound guidance in all 3 patients. Bronchoscopy was performed to confirm tube position and perform pulmonary toilet. No complications occurred.

CONCLUSIONS: It is feasible to perform PDT on intubated COVID-19 patients using the AerosolVE negative-pressure tent. This is a promising low-cost device to decrease risk to healthcare providers during AGPs.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Rajajee V, Williamson CA. Use of a Novel Negative-Pressure Tent During Bedside Tracheostomy in COVID-19 Patients. Neurocrit Care. 2020. PMID: 32770341. doi:10.1007/s12028-020-01068-1

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。